XNK Therapeutics is focused on realizing the potential in autologous NK cell therapies for cancer patients.

Pharmaceutical

XNK Therapeutics

XNK Therapeutics' headquarters in Huddinge, Sweden

Michael Uhlin

Hans Ericson

Zahra Rajabkhani

Stephan Meinke

Paul Do

Hans Gustaf Ljunggren

Gunnar Mattsson

Vera Franzén

Lena Degling Wikingsson

The Research and Development team at XNK Therapeutics is dedicated to advancing autologous NK cell therapies for cancer treatment. Comprised of experts in scientific research, regulatory affairs, and clinical operations, the team collaborates to design and execute innovative studies, ensure regulatory compliance, and streamline the production of therapeutic products, ultimately driving the development of effective cancer therapies.

Research and Development

The Leadership Team at XNK Therapeutics drives the strategic vision and operational effectiveness of the company, focusing on advancing autologous NK cell therapies for cancer treatment. Comprising the Chief Executive Officer, Chief Scientific Officer, and Chief Financial Officer, this team collaborates to navigate the complex landscape of biotech, ensuring scientific innovation aligns with financial sustainability and regulatory compliance to meet the needs of patients and stakeholders alike.

XNK Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

XNK Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Related companies